血清阿德罗宾水平作为预测糖尿病病进展的潜在生物标志物
I-Wen Chen1,2, Cheng-Wei Lin1,2,3, Chia-Ni Lin4,5
1Division of Endocrinology and Metabolism, Department of Internal Medicine, Chang Gung Memorial Hospital, Linkou Medical Center, Taoyuan, Taiwan.
Frontiers in endocrinology
|February 24, 2025
概括
血清阿德罗宾水平可以预测慢性病 (CKD) 在2型糖尿病 (T2D) 患者的进展. 较高的阿德罗宾水平与更快的CKD进展有关,这表明其作为生物标志物的潜力.
科学领域:
- 内分泌学 在内分泌学.
- 腎臟病學 (nephrology) 是一種醫學專業.
- 代谢疾病 代谢疾病
背景情况:
- 2型糖尿病 (T2D) 是慢性病 (CKD) 的一个主要风险因素.
- 识别T2D中CKD进展的生物标志物对于及时干预至关重要.
- 血清阿德罗宾在T2D相关脏疾病中的作用需要进一步调查.
研究的目的:
- 评估血清阿德罗宾作为预测性生物标志物,用于T2D个体中CKD进展.
- 为了确定阿德罗宾水平与T2D患者估计的膜过率下降的速度之间的关联.
主要方法:
- 测量了T2D患者在各种CKD阶段和健康对照中的血清阿德罗宾水平.
- 慢性瘤进展被定义为估计的膜过率下降≥30%.
- 使用后勤回归分析来评估阿德罗水平与CKD进展之间的联系.
主要成果:
- 与对照组相比,T2D患者的血清阿德罗宾水平显著更高.
- 在T2D队列中,晚期CKD的adropin水平升高.
- 在经历了CKD进展的T2D患者中观察到更高的阿德罗宾水平 (86%的敏感性,在特定的切线处70%的特异性).
- 在对共变量进行调整后,阿德罗平和CKD进展之间的关联仍然显著.
结论:
- 血清腺显示出作为T2D中CKD进展的预测生物标志物的潜力.
- 需要进一步的研究来验证这些发现并阐明潜在的生物机制.
- 阿德罗可能为糖尿病人群中脏疾病的管理提供了一个新的目标.
相关概念视频
01:17Factors Affecting Renal Clearance: Renal Impairment
48
Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
48
01:15Diabetes: Symptoms, Diagnosis, and Complications
497
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
497
01:33Hormonal Regulation
32.8K
The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
32.8K
01:11Renal Failure: Dose Adjustments
56
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
56
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
41
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
41